Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia

Katelyn E. Gagne, Roxanne Ghazvinian, Daniel Yuan, Rebecca L. Zon, Kelsie Storm, Magdalena Mazur-Popinska, Laura Andolina, Halina Bubala, Sydonia Golebiowska, Meghan A. Higman, Krzysztof Kalwak, Peter Kurre, Michal Matysiak, Edyta Niewiadomska, Salley Pels, Mary Jane Petruzzi, Aneta Pobudejska-Pieniazek, Tomasz Szczepanski, Mark D. Fleming, Hanna T. GazdaSuneet Agarwal

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Pearson marrow pancreas syndrome (PS) is a multisystem disorder caused by mitochondrial DNA (mtDNA) deletions. Diamond-Blackfan anemia (DBA) is a congenital hypoproliferative anemia in which mutations in ribosomal protein genes and GATA1 have been implicated. Both syndromes share several features including early onset of severe anemia, variable nonhematologicmanifestations, sporadic genetic occurrence, and occasional spontaneous hematologic improvement. Because of the overlapping features and relative rarity of PS, we hypothesized that some patients in whom the leading clinical diagnosis is DBA actually have PS. Here, we evaluated patient DNA samples submitted for DBA genetic studies and found that 8 (4.6%) of 173 genetically uncharacterized patients contained large mtDNA deletions. Only 2 (25%) of the patients had been diagnosedwithPSon clinical grounds subsequent to samplesubmission. We conclude that PS can be overlooked, and that mtDNA deletion testing should be performed in the diagnostic evaluation of patients with congenital anemia.

Original languageEnglish (US)
Pages (from-to)437-440
Number of pages4
JournalBlood
Volume124
Issue number3
DOIs
StatePublished - Jul 17 2014

Fingerprint

Diamond-Blackfan Anemia
Diamond
Mitochondrial DNA
Anemia
Pancreas
Ribosomal Proteins
Genes
DNA
Testing
VLCAD deficiency
Mutation

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Gagne, K. E., Ghazvinian, R., Yuan, D., Zon, R. L., Storm, K., Mazur-Popinska, M., ... Agarwal, S. (2014). Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia. Blood, 124(3), 437-440. https://doi.org/10.1182/blood-2014-01-545830

Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia. / Gagne, Katelyn E.; Ghazvinian, Roxanne; Yuan, Daniel; Zon, Rebecca L.; Storm, Kelsie; Mazur-Popinska, Magdalena; Andolina, Laura; Bubala, Halina; Golebiowska, Sydonia; Higman, Meghan A.; Kalwak, Krzysztof; Kurre, Peter; Matysiak, Michal; Niewiadomska, Edyta; Pels, Salley; Petruzzi, Mary Jane; Pobudejska-Pieniazek, Aneta; Szczepanski, Tomasz; Fleming, Mark D.; Gazda, Hanna T.; Agarwal, Suneet.

In: Blood, Vol. 124, No. 3, 17.07.2014, p. 437-440.

Research output: Contribution to journalArticle

Gagne, KE, Ghazvinian, R, Yuan, D, Zon, RL, Storm, K, Mazur-Popinska, M, Andolina, L, Bubala, H, Golebiowska, S, Higman, MA, Kalwak, K, Kurre, P, Matysiak, M, Niewiadomska, E, Pels, S, Petruzzi, MJ, Pobudejska-Pieniazek, A, Szczepanski, T, Fleming, MD, Gazda, HT & Agarwal, S 2014, 'Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia', Blood, vol. 124, no. 3, pp. 437-440. https://doi.org/10.1182/blood-2014-01-545830
Gagne KE, Ghazvinian R, Yuan D, Zon RL, Storm K, Mazur-Popinska M et al. Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia. Blood. 2014 Jul 17;124(3):437-440. https://doi.org/10.1182/blood-2014-01-545830
Gagne, Katelyn E. ; Ghazvinian, Roxanne ; Yuan, Daniel ; Zon, Rebecca L. ; Storm, Kelsie ; Mazur-Popinska, Magdalena ; Andolina, Laura ; Bubala, Halina ; Golebiowska, Sydonia ; Higman, Meghan A. ; Kalwak, Krzysztof ; Kurre, Peter ; Matysiak, Michal ; Niewiadomska, Edyta ; Pels, Salley ; Petruzzi, Mary Jane ; Pobudejska-Pieniazek, Aneta ; Szczepanski, Tomasz ; Fleming, Mark D. ; Gazda, Hanna T. ; Agarwal, Suneet. / Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia. In: Blood. 2014 ; Vol. 124, No. 3. pp. 437-440.
@article{323d5873ad6742aaa771fd74b0bfc920,
title = "Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia",
abstract = "Pearson marrow pancreas syndrome (PS) is a multisystem disorder caused by mitochondrial DNA (mtDNA) deletions. Diamond-Blackfan anemia (DBA) is a congenital hypoproliferative anemia in which mutations in ribosomal protein genes and GATA1 have been implicated. Both syndromes share several features including early onset of severe anemia, variable nonhematologicmanifestations, sporadic genetic occurrence, and occasional spontaneous hematologic improvement. Because of the overlapping features and relative rarity of PS, we hypothesized that some patients in whom the leading clinical diagnosis is DBA actually have PS. Here, we evaluated patient DNA samples submitted for DBA genetic studies and found that 8 (4.6{\%}) of 173 genetically uncharacterized patients contained large mtDNA deletions. Only 2 (25{\%}) of the patients had been diagnosedwithPSon clinical grounds subsequent to samplesubmission. We conclude that PS can be overlooked, and that mtDNA deletion testing should be performed in the diagnostic evaluation of patients with congenital anemia.",
author = "Gagne, {Katelyn E.} and Roxanne Ghazvinian and Daniel Yuan and Zon, {Rebecca L.} and Kelsie Storm and Magdalena Mazur-Popinska and Laura Andolina and Halina Bubala and Sydonia Golebiowska and Higman, {Meghan A.} and Krzysztof Kalwak and Peter Kurre and Michal Matysiak and Edyta Niewiadomska and Salley Pels and Petruzzi, {Mary Jane} and Aneta Pobudejska-Pieniazek and Tomasz Szczepanski and Fleming, {Mark D.} and Gazda, {Hanna T.} and Suneet Agarwal",
year = "2014",
month = "7",
day = "17",
doi = "10.1182/blood-2014-01-545830",
language = "English (US)",
volume = "124",
pages = "437--440",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

TY - JOUR

T1 - Pearson marrow pancreas syndrome in patients suspected to have Diamond-Blackfan anemia

AU - Gagne, Katelyn E.

AU - Ghazvinian, Roxanne

AU - Yuan, Daniel

AU - Zon, Rebecca L.

AU - Storm, Kelsie

AU - Mazur-Popinska, Magdalena

AU - Andolina, Laura

AU - Bubala, Halina

AU - Golebiowska, Sydonia

AU - Higman, Meghan A.

AU - Kalwak, Krzysztof

AU - Kurre, Peter

AU - Matysiak, Michal

AU - Niewiadomska, Edyta

AU - Pels, Salley

AU - Petruzzi, Mary Jane

AU - Pobudejska-Pieniazek, Aneta

AU - Szczepanski, Tomasz

AU - Fleming, Mark D.

AU - Gazda, Hanna T.

AU - Agarwal, Suneet

PY - 2014/7/17

Y1 - 2014/7/17

N2 - Pearson marrow pancreas syndrome (PS) is a multisystem disorder caused by mitochondrial DNA (mtDNA) deletions. Diamond-Blackfan anemia (DBA) is a congenital hypoproliferative anemia in which mutations in ribosomal protein genes and GATA1 have been implicated. Both syndromes share several features including early onset of severe anemia, variable nonhematologicmanifestations, sporadic genetic occurrence, and occasional spontaneous hematologic improvement. Because of the overlapping features and relative rarity of PS, we hypothesized that some patients in whom the leading clinical diagnosis is DBA actually have PS. Here, we evaluated patient DNA samples submitted for DBA genetic studies and found that 8 (4.6%) of 173 genetically uncharacterized patients contained large mtDNA deletions. Only 2 (25%) of the patients had been diagnosedwithPSon clinical grounds subsequent to samplesubmission. We conclude that PS can be overlooked, and that mtDNA deletion testing should be performed in the diagnostic evaluation of patients with congenital anemia.

AB - Pearson marrow pancreas syndrome (PS) is a multisystem disorder caused by mitochondrial DNA (mtDNA) deletions. Diamond-Blackfan anemia (DBA) is a congenital hypoproliferative anemia in which mutations in ribosomal protein genes and GATA1 have been implicated. Both syndromes share several features including early onset of severe anemia, variable nonhematologicmanifestations, sporadic genetic occurrence, and occasional spontaneous hematologic improvement. Because of the overlapping features and relative rarity of PS, we hypothesized that some patients in whom the leading clinical diagnosis is DBA actually have PS. Here, we evaluated patient DNA samples submitted for DBA genetic studies and found that 8 (4.6%) of 173 genetically uncharacterized patients contained large mtDNA deletions. Only 2 (25%) of the patients had been diagnosedwithPSon clinical grounds subsequent to samplesubmission. We conclude that PS can be overlooked, and that mtDNA deletion testing should be performed in the diagnostic evaluation of patients with congenital anemia.

UR - http://www.scopus.com/inward/record.url?scp=84904507797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904507797&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-01-545830

DO - 10.1182/blood-2014-01-545830

M3 - Article

C2 - 24735966

AN - SCOPUS:84904507797

VL - 124

SP - 437

EP - 440

JO - Blood

JF - Blood

SN - 0006-4971

IS - 3

ER -